AAAAAA

   
Results: 1-2 |
Results: 2
Attenuation and immunogenicity in humans of a live dengue virus type-4 vaccine candidate with a 30 nucleotide deletion in its 3 '-untranslated region
Authors: Durbin, AP Karron, RA Sun, W Vaughn, DW Reynolds, MJ Perreault, JR Thumar, B Men, R Lai, CJ Elkins, WR Chanock, RM Murphy, BR Whitehead, SS
Citation: Ap. Durbin et al., Attenuation and immunogenicity in humans of a live dengue virus type-4 vaccine candidate with a 30 nucleotide deletion in its 3 '-untranslated region, AM J TROP M, 65(5), 2001, pp. 405-413
Immunization of rhesus monkeys with a recombinant of modified vaccinia virus Ankara expressing a truncated envelope glycoprotein of dengue type 2 virus induced resistance to dengue type 2 virus challenge
Authors: Men, R Wyatt, L Tokimatsu, I Arakaki, S Shameem, G Elkins, R Chanock, R Moss, B Lai, CJ
Citation: R. Men et al., Immunization of rhesus monkeys with a recombinant of modified vaccinia virus Ankara expressing a truncated envelope glycoprotein of dengue type 2 virus induced resistance to dengue type 2 virus challenge, VACCINE, 18(27), 2000, pp. 3113-3122
Risultati: 1-2 |